Cue Biopharma, Inc.
NASDAQ:CUE · NASDAQ Capital Market
+$0.38 today
Vol 0.16M · Avg 0.74M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+44.83%
Period High
$35.73
Period Low
$5.31
Latest
$28.46
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Century Therapeutics, Inc.
NASDAQ:IPSC
$197.55M
Equillium, Inc.
NASDAQ:EQ
$107.81M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$70.29M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$69.75M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$64.18M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
Barinthus Biotherapeutics plc
BRNS
$28.13M
Senti Biosciences, Inc.
SNTI
$24.61M
Medicus Pharma Ltd. Common Stock
MDCX
$9.72M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest CUE filing?
The latest filing shown is EFFECT dated Jun 17, 2026.
How many recent filings does CUE have?
Intrinsic Alpha currently shows 20 recent filings for CUE.
Explore More
Continue the stock analysis
Jump to another research area for this company.